Viatris (VTRS) Current Taxes (2019 - 2025)
Viatris (VTRS) posted Current Taxes of $124.0 million for Q4 2025, up 32.76% on a QoQ basis from $93.4 million in Q1 2025, and down 35.65% year-over-year from $192.7 million in Q4 2024.
Analysis
Viatris (VTRS) Current Taxes (2019 - 2025) Analysis & Trends
Viatris has reported Current Taxes for 7 years, with the latest figure at $124.0 million in Q4 2025.
- On a quarterly basis, Current Taxes fell 35.65% year-over-year to $124.0 million in Q4 2025; TTM through Dec 2025 was $124.0 million, a 35.65% decrease from a year earlier, with the FY2025 full-year figure at $124.0 million, down 35.65% from the prior year.
- Current Taxes was $124.0 million for Q4 2025 at Viatris, up from $93.4 million in the prior quarter.
- The five-year high for Current Taxes was $752.0 million in Q1 2021, with the low at $93.4 million in Q1 2025.
- Average Current Taxes over 5 years is $239.4 million, with a median of $195.4 million recorded in 2021.
- The sharpest annual moves came in 2022 and 2023: Current Taxes tumbled 80.24% in 2022, then soared 93.91% in 2023.
- Over 5 years, Current Taxes stood at $236.9 million in 2021, then rose by 18.02% to $279.6 million in 2022, then dropped by 18.88% to $226.8 million in 2023, then decreased by 15.04% to $192.7 million in 2024, then slumped by 35.65% to $124.0 million in 2025.
- The last three Current Taxes figures came in at $124.0 million (Q4 2025), $93.4 million (Q1 2025), and $192.7 million (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.53 Bn | 38.88 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.14 Bn | 18.25 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | 45.00 Mn |
| 4 | Amneal Pharmaceuticals | 5.45 Bn | 5.33 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.33 Bn | 492.63 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.51 Bn | 1.36 Bn | 2.56 Mn | 2.00 Mn |
| 7 | Ani Pharmaceuticals | 1.48 Bn | 1.12 Bn | 165.89 Mn | 3.53 Mn |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn | 546,000.00 |
| 9 | Fennec Pharmaceuticals | 400.20 Mn | 358.95 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.79 Mn | 178.79 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 124.00 Mn |
| Mar 31, 2025 | 93.40 Mn |
| Dec 31, 2024 | 192.70 Mn |
| Sep 30, 2024 | 284.10 Mn |
| Jun 30, 2024 | 117.70 Mn |
| Mar 31, 2024 | 148.40 Mn |
| Dec 31, 2023 | 226.80 Mn |
| Sep 30, 2023 | 206.90 Mn |
| Jun 30, 2023 | 158.10 Mn |
| Mar 31, 2023 | 244.50 Mn |
| Dec 31, 2022 | 279.60 Mn |
| Sep 30, 2022 | 106.70 Mn |
| Jun 30, 2022 | 125.70 Mn |
| Mar 31, 2022 | 177.80 Mn |
| Dec 31, 2021 | 236.90 Mn |
| Sep 30, 2021 | 198.00 Mn |
| Jun 30, 2021 | 636.00 Mn |
| Mar 31, 2021 | 752.00 Mn |
| Dec 31, 2020 | 288.60 Mn |
| Dec 31, 2019 | 213.00 Mn |